AnvilCore Research
CJC-1295 w/DAC research material is available in 2 formats. Select a tab to review the available strength.
Technical research description
CJC-1295 with DAC is a long-acting analogue of growth-hormone-releasing hormone. Its drug-affinity-complex modification promotes albumin binding and prolonged exposure; controlled human studies reported sustained, dose-dependent changes in circulating growth hormone and IGF-1.
CJC-1295 with DAC is a long-acting analogue of growth-hormone-releasing hormone. Its drug-affinity-complex modification promotes albumin binding and prolonged exposure; controlled human studies reported sustained, dose-dependent changes in circulating growth hormone and IGF-1.
Amino-acid sequence
Tyr — D-Ala — Asp — Ala — Ile — Phe — Thr — Gln — Ser — Tyr — Arg — Lys — Val — Leu — Ala — Gln — Leu — Ser — Ala — Arg — Lys — Leu — Leu — Gln — Asp — Ile — Leu — Ser — Arg — Lys(DAC) — NH₂
Modified GRF backbone with a maleimidopropionyl drug-affinity-complex group on the terminal lysine.
CJC-1295 w/DAC — 5 mg
- Strength
- 5 mg
- Format
- Powder
- Retail price (USD)
- $54.00
Adds CJC-1295 w/DAC — 5 mg to your cart. Research and laboratory use only.
CJC-1295 w/DAC — 10 mg
- Strength
- 10 mg
- Format
- Powder
- Retail price (USD)
- $99.20
Adds CJC-1295 w/DAC — 10 mg to your cart. Research and laboratory use only.
Research use only. Not for human consumption or clinical, diagnostic, or therapeutic use.